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Background. Colorectal cancer is the third most prevalent cancer worldwide, which is less common in the Middle East;
its prevalence demonstrated to be 7 persons per 100,000 populations in Iran. In this study, we aimed to investigate the
clinicopathologic features of CRC patients in West Azerbaijan province of Iran. Methods. In this crosssectional study, 546 patients
who underwent surgical procedures with the pathologic diagnosis of colorectal cancer in both academic and private hospitals of
Urmia were enrolled. Results. The mean age at diagnosis was 55.2 ± 11.5 years. 23% had an age lower than forty years old. Rectal
bleeding (26%), abdominal pain (25%), and large bowel obstruction (23%) were three most common presenting symptoms.
26% of patients presented with acute abdomen. 95% of tumors were adenocarcinoma, 4% were lymphoma, and 1% was other
rare tumors. Regarding the stage of cancer according to TNM staging system, 6% of patients were in stage I, followed by 37%
in stage II, 33% in stage III, and 24% in stage IV. In 44.5% of patients, the tumor was located in rectum. Conclusion.I nw e s t
Azerbaijan province of Iran, patients with colorectal cancer present in younger age and more advanced stages in comparison with
the developed countries.
1.Introduction
Colorectal cancer (CRC) is the third most common cause of
cancer diagnosed in the United States and the second leading
cause of cancer death [1]. According to the reports, every 9
minutes, someone dies from CRC [2] .C R Ci sl e s sc o m m o n
in the Middle East [3]. Also, in WHO EMRO region, it
has the 3rd place among the most common cancers (3rd
place after breast and cervical cancer in women and 5th
place after lung, bladder, stomach cancer, and non-Hodgkin
lymphoma) [4].
Colorectal cancer is the 3rd and the 4th most commonly
diagnosed cancer, respectively, in Iranian men and women
[5]. The prevalence of CRC demonstrated to be 7 persons
per 100,000 population in Iran [6]. 5000 new Iranian cases
of CRC reported each year [5]. Although there is some
information about the situation of CRC, from diﬀerent
regions of Iran, no speciﬁc data were available regarding the
prevalence and clinicopathologic characteristics of CRC in
West Azerbaijan province located in the northwestern Iran.
In this study, we aimed to investigate the clinicopathologic
features of CRC patients in West Azerbaijan province of Iran.
2.MaterialandMethods
This hospital-based cross-sectional descriptive study was
approved by the Scientiﬁc and Ethical Review Board of
Urmia University of Medical Sciences. It was conducted
at academic training and private hospitals of Urmia, the
capital of West-Azerbaijan province. The location of West
Azerbaijan province in the northwest of Iran is depicted
in Figure 1. This ﬁgure also demonstrated the Tehran,
Markazi, Hamadan, Kurdistan, Golestan, and Mazandaran
provinces from which previous Iranian studies regarding the
epidemiology of colorectal cancer were reported.
546 patients who underwent surgical procedures with
the pathologic diagnosis of colorectal cancer within 8 years
(2001–2008) were enrolled in this study. The following data
were obtained: age at diagnosis, gender, presenting symp-
toms (including abdominal pain, change in bowel habit,2 ISRN Gastroenterology
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Figure 1: The location of West Azerbaijan province (Our study) in
the northwest of Iran, compared to the place of previous reports
from Iran (the Tehran, Markazi, Hamadan, Kurdistan, Golestan,
and Mazandaran provinces).
hematochezia or melena, weakness, anemia, and weight
loss), anatomical site of tumor, and pathological type of
tumor (grade and stage of tumor).
In this study, the TNM (tumor, lymph nodes, metas-
tasis) staging system was used for determining the severity
of disease and the local or distant extent of disease spread.
The TNM staging system of the American Joint Committee
on Cancer (AJCC) is the preferred staging system for CRC.
Statistical analysis was performed using SPSS software
ver16 package. Frequencies were provided using descriptive
statistics.
3. Results
A total of 546 patients were enrolled in this study. 306
patients (56%) were men, and 240 (44%) were women. The
mean age at diagnosis was 55.2 ± 11.5y e a r so l d .A m o n g
patients, 33.6% had an age lower than ﬁfty, 43.4% were
between 50 and 69 years, and 22.9% had an age higher than
70 years old. 23% of patients had an age lower than forty
years old.
The presenting symptoms were rectal bleeding (26%),
abdominal pain (25%), large bowel obstruction (23%),
change in bowel habits (14%), weakness and anemia (5%),
abdominal mass (4%), and bowel perforation and peritonitis
(3%). Overall, in 26% of them, the patients were presented
with acute abdomen due to bowel obstruction, perforation,
or the like.
Regardingthehistologicaldiagnosis,95%oftumorswere
adenocarcinoma, 4% were lymphoma, and 1% was other
rare tumors. About the grade of tumor, 64% had well-
differentiated tumors, followed by moderately and poorly
differentiated tumors, respectively, in 30% and 6% of pa-
tients.
Regarding the stage of cancer according to TNM staging
system, 6% of patients were in stage I, followed by 37% in
stage II, 33% in stage III, and 24% in stage IV.
The tumor was located in rectum in 244 patients
(44.5%), right colon in 192 patients (35%), and left colon
in 110 cases (20%).
4. Discussion
The prevalence of cancer in Iran is much higher than
the universal average (160 per 100,000 Iranian population
compared to 66.8 and 73.9 per 100,000 for women and
men worldwide). This rate is 201 cases per each 100,000
population for the West Azerbaijan province, which is
signiﬁcantly higher than other parts of the country. West
Azerbaijan has the forth place after Guilan (223.4/100,000),
Isfahan (218/100,000), and Yazd (217.4/100,000) provinces
[7]. Colorectal cancer is the third most common cancer
worldwide. Esna-Ashari et al. investigated the prevalence of
colorectal cancer in Iran according to the survival data in a
5-year period (2001–2005) and estimated the prevalence in
the 1st year, 2nd-3rd, and 4th-5th years to be 4156, 5715,
and 4283 cases. The cumulative prevalence in these 5 years
was 13954 cases, but despite the high rate of new cases, the
pointprevalencewasnotconsiderablychangedinthisperiod
[8]. According to the study of Moghimi-Dehkordi et al., the
Kaplan-Meier indicated the 1-, 3-, 5-, 10-, 15-year survival
rates of Iranian CRC patients to be 91.1, 73.1, 61, 54.9, 25,
and 9 percent, respectively [9].
There is a paucity of data regarding the colorectal cancer
from northwestern provinces of Iran. Some important char-
acteristics demonstrated in our ﬁndings were listed as fol-
lows.
Age Distribution. The mean age of our patients was 55.2 ±
11.5 years old. The age distribution of CRC patients, men-
tioned in diﬀerent Iranian studies varies, from 51 years in
Kurdistan province to almost 60 in Tehran. CRC patients in
central provinces such as Tehran (59.7 years) [10], Hamedan
(58.6 years) [11], and Markazi (56.2 years) [12]s e e mt oh a v e
higher age than patients from northern and north western
provinces of the country (Gorgan: 52–56 years [13, 14],
Mazandaran: 52 [5], West Azerbaijan: 55, and Kurdistan: 51
years old [6]). Only the study of Jalali et al. from Tehran
province reported a low mean age such as 51 years old,
which could be due to the referral nature of the Imam-
Khomeini General Hospital, in which the mentioned study
was conducted [15]. The patients, who referred to Imam
Khomeini Hospital of Tehran (the capital of Iran) from
other provinces, may carry the characteristics of CRC in
their region to the capital. Although mean age is generally
in concordance with other studies (in a range between 51
and 59 years old), the ratio of patients with an age under
forty was demonstrated to be 23% in our province, which
is against many other studies. For example in the study of
Li et al. in China, 10% of their patients have an age under
40 [16]. Of course our ﬁndings are similar to the ﬁndings of
Jalali et al. (26%) in Tehran [15]. Considering the fact that
colorectal cancer in younger ages may be more due to some
probable genetic or familial factors, the genetic and familial
background of the CRC patients in our province should
be investigated in further studies. Also the more advancedISRN Gastroenterology 3
cancer stage in the patients aged below 50 years needs to
make the treating physicians more aware of the fact that
CRC can occur even at this age [17]. Of course some studies
demonstrated that, in younger ages, the cancer is presented
with diﬀerent features (anatomical site, stage of tumor, etc.),
but young age by itself was not found to impact patient
outcome [16, 18].
Presenting Sign and Symptom. In this study, 26% of subjects
were presented with acute abdomen because of bowel
obstruction or perforation, which is against the ﬁndings of
others that reported acute and subacute presentation in less
than 10% of their patients. It is important because subacute
presentations make the appropriate treatment impossible
[19, 20]. Delay in diagnosis may be due to overlooking
the alarming sign and symptoms by both the patients and
physicians. The patient may neglect the alarming signs, and,
on other hand, the physician may attribute the patient’s
symptomstootherbenignanorectaldiseases.Theevidenceis
the frequencyofpatients that underwent hemorrhoidectomy
several months prior to deﬁnitive diagnosis of colorectal
cancer. This ﬁnding suggests the need for implementing an
extensive educational program on general population about
the importance of alarming sign and symptoms including
changes in bowel habits.
Pathology. In our study, the pathology of tumor was adeno-
carcinoma in 95%, lymphoma in 4%, and rare tumors in 1%
which is similar to several other reports [5, 6, 11, 12, 14, 21–
23].
Stage of Tumor. Unfortunately57% of our patients were pre-
sented in 3rd or 4th stage. This is in accordance with
other reports from Iran [15] ,b u tt h i si si nc o n t r a s tw i t h
reports from other parts of the world (30% for the 3rd and
4th stage in the study of Liu et al. in China) [19]. This
deplorableﬁndingasmentionedpreviouslycanbeattributed
to overlooking the alarming sign and symptoms by the
patients and/or the physicians, and mainly due to the lack of
an appropriate screening program for CRC in our province,
as well as country.
Site of Tumor. The most prevalent site of tumor was rectum
(almost 45%) in our study, unlike in the United States and in
concordance with many other studies from this region [3].
The 65% of tumors were located after the splenic ﬂexure.
This proposes the applicability of colonoscopy in screening
CRC in west Azerbaijan and other parts of Iran.
The increasing incidence of right-sided CRC has been
noted in some developed countries; thus, they had to change
their screening methodology and to consider other measures
such as CT colonography or stool DNA tests beside the more
invasive colonoscopy method [1, 17].
According to the literature, survival improves substan-
tiallyifthecolorectalcancerisdiagnosedwhileitisstilllocal-
ized[2].Thereareseveralevidencessupportingthescreening
of individuals over the age of 50 years to detect and prevent
colorectal cancer [1, 15].
Of course it should be noted that, even in countries
such as the United States with strong protocols in favor
of performing CRC screening programs, every 5 seconds
someone who should be screened for CRC is not. And only
one third of people who expected to have CRC are screened
for it. Unfortunately, 20% of CRC patients who do receive
screening demonstrated to be diagnosed in the later, less-
treatable stages [2].
Developing a road map for ﬁnding the most appropriate
screening method and the best age cutoﬀ for performing
the CRC screening in Iran is recommended. Reviewing the
experience of screening programs in developed countries
such as the US could help us in reaching a successful national
screening program. The measures should be taken to max-
imize the compliance of patients and physicians with the
mentioned screening program.
Our limitation in studying the clinicopathologic features
of CRC patients in west Azerbaijan province was the
population we enrolled that all of them were the patients,
which their disease ended to surgery. The patients who die at
end stages of cancer without any surgical intervention, or the
CRC patients who have not received any surgical treatment
yet, were not included in our study.
5. Conclusion
In conclusion, in west Azerbaijan province of Iran, patients
with colorectal cancer present in younger age and more
advancedstagesincomparisonwiththedevelopedcountries,
in which almost 60% of CRC cases occur. The authors
emphasize on the importance of implementing an appropri-
ate screening program with considering the region-speciﬁc
characteristics of CRC patients.
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